Update on ECMO for COVID-19: What have we learned? Early experience of pump-controlled retrograde trial off for weaning from (VA ECMO) in adult patients with cardiogenic shock
Unwanted intravascular material and its consequences w/Case studies Introducing the AngioVac Gen 3. Incorporating AngioVac Gen 3 into a comprehensive Pulmonary Embolism
Peripartum cardiogenic shock can happen, though infrequently, is devastating. Learn about this complex condition and hear case studies on successful outcomes with the use of ECMO